Immunoglobulin M pemphigoid

  • Katharina Boch
  • Christoph M Hammers
  • Stephanie Goletz
  • Mayumi Kamaguchi
  • Ralf J Ludwig
  • Stefan W Schneider
  • Detlef Zillikens
  • Eva Hadaschik
  • Enno Schmidt

Abstract

BACKGROUND: Pemphigoid diseases are a heterogeneous group of autoimmune blistering disorders characterized by predominant deposition of immunoglobulin G or immunoglobulin A autoantibodies against structural proteins of the dermoepidermal junction (DEJ). Sole linear immunoglobulin M (IgM) deposits at the DEJ in pemphigoid diseases have been observed; however, IgM-specific target antigens have not been identified.

OBJECTIVE: Characterization of patients with IgM pemphigoid.

METHODS: Skin biopsy specimens and sera from IgM-positive patients were assessed using histopathology, direct and indirect immunofluorescence microscopy, enzyme-linked immunosorbent assays, immunoblotting, cryosection assay, complement fixation test, and internalization assays.

RESULTS: Tissue-bound linear IgM deposits along the DEJ and circulating IgM autoantibodies against type XVII collagen (Col17) were detected. These circulating IgM autoantibodies showed no complement activating or blister inducing capacity, but the ability of Col17 internalization ex vivo.

LIMITATIONS: Limited number of patients.

CONCLUSION: This study provides further evidence for the role of IgM autoantibodies in pemphigoid disease and highlights Col17 as a target antigen in IgM pemphigoid.

Bibliografische Daten

OriginalspracheEnglisch
ISSN0190-9622
DOIs
StatusVeröffentlicht - 12.2021

Anmerkungen des Dekanats

Copyright © 2021 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

PubMed 33453342